La Trobe University leads $4.74 million project into non-toxic weed control management in Australia
More than $4.7 million has been pledged for a project looking at a non-toxic, environmentally friendly method of controlling weeds and pests in horticultural crops in Australia.
The five-year study La Trobe University-led project will investigate the usefulness of anaerobic soil disinfestation technology within the Australian environment — technology which has already proved successful in the United States and is now being widely adopted.
it is hoped it could offer Australian growers sustainable alternatives to chemical-based approaches to weed management, as well as enhancing the profitability of growers by reducing input costs of production.
Hort Innovation research and development manager Araz Solomon said the project was important for the future of horticulture in Australia.
'This project represents an important investment in sustainable horticultural production,' he said.
'It forms part of a broader series of initiatives led by Hort Innovation, all aimed at improving weed management outcomes and delivering practical, science-based solutions that ensure the long-term success of the horticulture industry.'
The project will target crops grown on plastic mulch such as strawberries, capsicums and melons in Victoria and the Northern Territory.
Project lead Ali Bajwa said fumigation with chemicals was the main approach for controlling certain weeds and soil-borne pathogens in plasticulture-based horticulture crops in Australia.
'As more of these damaging chemicals get banned for use in horticulture due to environmental safety concerns, we will need a reliable alternative weed control approach that is good for the environment and achieves circular economy benefits by putting farm byproducts to a great use,' he said.
ASD involves the use of plant-based carbon sources, moisture and plastic soil coverings to create an oxygen-deprived environment which is hostile to weeds and soil-borne pathogens, causing them to die.
Carbon sources will include biowaste products such as chicken manure, rice bran, sugarcane molasses and cottonseed meal.
Once weeds are controlled, the soil microbiome can be returned to an optimal, oxygen-rich aerobic environment for growing crops, enhancing harvest quantity and quality.
Senior lecturer in weed science and agronomy Mr Bajwa said the goal was to determine the optimal combinations of bio-amendments and treatment strategies which would achieve the best weed control outcomes.
'We will work closely with growers, industry partners and extension groups to share our findings and drive adoption of this technology,' he said.
The study is funded through Hort Innovation Frontiers with co-investment from La Trobe University, the Department of Agriculture and Fisheries Northern Territory and contributions from the Australian Government.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
6 hours ago
- News.com.au
La Trobe researchers warn gazania garden plant sold at Bunnings is ‘highly invasive'
A popular garden plant sold at Bunnings is even more invasive and potentially dangerous to Australia's natural environment than originally thought, new research has revealed. La Trobe scientists, writing in the Frontiers journal, warn that gazania daisies, a brightly coloured ornamental plant sold in nurseries nationwide, is a 'highly-invasive plant' that is beginning to impact grain production and grasslands across southern Australia. The plant can germinate and thrive in almost all conditions, the report shows, regardless of moisture, temperature or salinity levels. 'Due to its flexible growth requirements, gazania is now widespread and naturalised in a variety of habitats including coastal sand dunes, stream banks, wastelands, open grasslands, along roadsides and on cultivated and irrigated sites,' the report states. 'While gazania has long been considered as an environmental weed in Australia, a trend of 'jumping the fence' has been observed in recent years, infesting grain crop production fields in low-rainfall regions of South Australia. 'The presence of gazania in cropping fields is proving highly problematic, with farmers finding it difficult to control with common herbicides.' The researchers warn the weed is now 'rapidly spreading' across Australia and urgent long-term management strategies are needed to control the invasion. Gazania is native to South Africa and was introduced into Australia in the 1950s and 1970s. Invasive Species Council advocacy manager Imogen Ebsworth said the daisies should be banned from sale immediately. 'Gazanias are the perfect example of an escaped invasive garden plant that needs to be banned from sale,' she said. 'They are already banned in South Australia, but it's clear we need them pulled nationally. 'I urge the nursery industry to act on this new evidence and stop selling it … we've seen this story unfold far too many times. Ornamental plants that turn into unstoppable weeds, costing us billions in control efforts and wiping out native species in the process.' The council estimates more than 30,000 plant species have been imported into Australia for gardening, but 'fewer than a quarter' have been assessed nationally for their weed risk. Weeds cost the country more than $5bn a year in agricultural and environmental damage, the council said, with 'escaped' ornamental plants making up more than 70 per cent of the country's environmental weeds. Garden plants can escape and germinate in the wild via garden waste, lawn clippings and seed dispersal. Bunnings continues to sell gazanias, NewsWire has confirmed. According to the retail giant, each state and territory has its own list of declared weeds and laws and regulations for invasive weeds. The plants Bunnings sells across its stores differ depending on where they are sold and their declaration status. 'Like many nurseries and retailers, we sell a wide range of locally sourced plants across our stores and we work hard to create an assortment that caters to customer preferences and demand,' Bunnings director of merchandise Cam Rist said. 'As always, we closely follow all relevant local biosecurity regulations and the advice of regulators about the plants we sell.' The plant is also sold at other nurseries, including online marketplaces. The council argues 'self-regulation' has not worked and wants a federal government response. 'We've spent decades relying mainly on self-regulation, which just doesn't work,' Ms Ebsworth said. 'You can still legally buy plants that are banned in neighbouring states or overseas. 'Unless governments act, we'll keep selling the next lantana, the next gazania, straight into our backyards and bushland.'
9 News
10 hours ago
- 9 News
Wendy's cancer might be incurable, but she just wants to help future patients
Your web browser is no longer supported. To improve your experience update it here When Wendy Clift went for a routine breast scan in 2007, she got call from her doctors almost immediately. "The news wasn't good," the widowed grandmother of two from Scone in regional NSW told Wendy Clift was diagnosed with breast cancer in 2007. (Supplied) Just days later, she had a mastectomy, followed by more treatment. While it was successful in keeping her in remission for a few years, the cancer has now returned and it has spread. However, Clift, now 72, was invited to be part of a new Australian drug trial. It's hoped it could help patients with a certain kind of breast cancer live longer. The DIAmOND clinical trial showed adding dual immunotherapy to existing treatments could be promising for some patients with advanced HER2-positive breast cancer. Clift said her cancer appears to be "pretty stable" after the trial earlier this year, which she did at Lake Macquarie Private Hospital. Some of the cancerous lumps she had have even disappeared, though she doesn't know if that's due to the new drug combination. Clift said she didn't have side effects. She said taking part in the trial was less about her and more to help future patients. "I'm just prepared because whatever happens to me is neither here nor there, but hopefully in years to come it'll help somebody else," she said. Immunotherapy is a treatment that uses a person's immune system to treat certain cancers. Wendy Clift, pictured with son Joshua and grandchildren Florence and Arthur, says she just wants to help future cancer patients. (Supplied) The other drug used alongside this in the trial was trastuzumab, commonly known as Herceptin. The trial aimed to see if combining the two could prolong the amount of time cancer was under control in patients with advanced disease which had become resistant to trastuzumab. Results differed depending on the kind of cancer each of the 68 trial patients had. Some had a response rate of up to 63 per cent, while for other kinds it was 27 per cent. Some patients saw their cancer controlled for more than two years. The combination of drugs has been given previously to people with lung cancer. Professor Sherene Loi developed and led the trial, which was conducted by the research organisation Breast Cancer Trials. "These promising results suggest combining new immunotherapy treatments with trastuzumab may offer a new treatment option for patients with treatment-resistant HER2-positive breast cancer," Loi said. "These findings provide a compelling case for further exploration and how we can best integrate this treatment combination into clinical practice." HER2-positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). However, it often responds well to specific treatments. Around 15-20 per cent of all types of breast cancers are HER2-positive. It is more common in younger, pre-menopausal women. cancer health drugs Australia medical national New South Wales CONTACT US Auto news:Is this the next Subaru WRX? Mysterious performance car teased.
Perth Now
a day ago
- Perth Now
‘Overwhelmed': Major virus breakthrough
Australian researchers have found a way to force the HIV virus out of hiding within cells, opening the way to eradicate the virus from the body. The human immunodeficiency virus is able to hide within white blood cells, presenting a serious roadblock for scientists pursuing a cure. Research from Melbourne's Peter Doherty Institute for Infection and Immunity, published in late-May, says work towards a cure is one step closer. The next hurdle is analysing whether revealing the virus allows the body's immune system to fight off the virus or if additional treatments need to be combined. Australian researchers are closer to a HIV cure. Credit: News Limited 'In terms of specifically the field of HIV cure, we have never seen anything close to as good as what we are seeing in terms of how well we are able to reveal this virus,' co-author Paula Cevaal told the Guardian. 'We were overwhelmed by how night-and-day difference it was – from not working before, and then all of a sudden it was working. And all of us were just sitting gasping like, 'Wow'.' The HIV that hides in white blood cells can reactivate. The Peter Doherty Institute researchers used custom-made fat bubbles to deliver mRNA into cells where HIV is hiding. The mRNA tells the cells to reveal the virus. Messenger RNA is a molecule that contains instructions for cells to make a protein. The technology rose to prominence during the Covid-19 pandemic. People with HIV have to take medication for their entire life to suppress the virus, avoid symptoms and to stop transmission to other people. About 30,000 Australians live with HIV. In 2023, 722 new cases were reported to health authorities. Globally, in 2023, an estimated 500,000 to 820,000 people died from HIV-related causes.
